TRABECTOME FOR MINIMALLY INVASIVE GLAUCOMA TREATMENT
Traditional glaucoma procedures include multi-drug approaches, lasers, eyedrops
and even surgical interventions with unpredictable outcomes. Trabectome is
different. Taking a cue from nature, Trabectome works to help the body help
itself. Designed to improve fluid drainage from the eye and balance intraocular
pressure, this minimally invasive procedure stabilizes optic nerve health to
minimize further visual field damage.
Trabectome is an FDA-cleared device for minimally invasive surgical treatment of
open angle glaucoma. It safely ablates and removes a 60°-120° strip of
trabecular meshwork using a focused electrosurgical pulse and re-establishes
access to the eye’s natural drainage pathway. Glaucoma surgeons across the
United States and internationally have successfully used Trabectome on hundreds
of patients since 2004.
TRABECTOME ADVANTAGE
• Restores the eye’s natural drainage pathways
• Low patient risk
• Simpler than traditional therapies
• Low complication rate
• Easily combines with cataract extraction
• Safe, economical and effective
SCANNING ELECTRON MICROSCOPE IMAGES
Trabectome Removal of TM on Autopsy Eye: Collector channel, outer wall of
Schlemm's canal. Ostium is intact, allowing aqueous free access to episcleral
vessels. (Images and descriptions from Douglas Johnson, MD)